Drug Shortage Report for ZITHROMAX FOR INTRAVENOUS INJECTION

Last updated on 2019-07-10 History
Report ID 72813
Drug Identification Number 02239952
Brand name ZITHROMAX FOR INTRAVENOUS INJECTION
Common or Proper name ZITHROMAX
Company Name PFIZER CANADA ULC
Active Ingredient(s) AZITHROMYCIN
Strength(s) 500MG
Dosage form(s) POWDER FOR SOLUTION
Route of administration INTRAVENOUS
Packaging size 10 x 5 mL
ATC code J01FA
ATC description MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2019-01-16
Estimated end date
Actual end date 2019-07-09
Shortage status Resolved
Updated date 2019-07-10
Company comments
Health Canada comments
Contact Address 17300 TRANS-CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v12 2019-07-10 French Compare
v11 2019-07-10 English Compare
v10 2019-06-03 French Compare
v9 2019-06-03 English Compare
v8 2019-05-27 French Compare
v7 2019-05-27 English Compare
v6 2019-04-17 French Compare
v5 2019-04-17 English Compare
v4 2019-03-27 French Compare
v3 2019-03-27 English Compare
v2 2019-01-17 French Compare
v1 2019-01-17 English Compare